Connect with us

Hi, what are you looking for?

POZ

New HIV strain recorded under same group that caused pandemic

The discovery marks the first time a new subtype of HIV-1 has been identified since 2000. To stress, though: Existing treatments for HIV are effective against variants of the HIV virus, including the new subtype.

Photo by Belova59 from Pixabay.com

A team of its scientists identified a new subtype of the human immunodeficiency virus (HIV), called HIV-1 Group M, subtype L. This marks the first time a new subtype of “Group M” HIV virus has been identified since guidelines for classifying new strains of HIV were established in 2000.

Group M viruses are responsible for the global pandemic, which can be traced back to the Democratic Republic of Congo (DRC) in Sub-Saharan Africa.

The findings of the study – titled “Complete genome sequence of CG-0018a-01 establishes HIV-1 subtype L” – was published in the Journal of Acquired Immune Deficiency Syndromes (JAIDS).

“In an increasingly connected world, we can no longer think of viruses being contained to one location,” said Carole McArthur, Ph.D., M.D., professor in the departments of oral and craniofacial sciences, University of Missouri — Kansas City, and one of the study’s authors. “This discovery reminds us that to end the HIV pandemic, we must continue to outthink this continuously changing virus and use the latest advancements in technology and resources to monitor its evolution.”

Since the beginning of the global AIDS pandemic, 75 million people have been infected with HIV and 37.9 million people today are living with the virus.

To determine if a virus is in fact a new HIV subtype, three cases must be discovered independently. In this case, the first two samples of this subtype were discovered in DRC in the 1980s and the 1990s. The third, collected in 2001, was difficult to sequence at that time because of the amount of virus in the sample and the existing technology.

With next-generation sequencing technology now available, researchers can build an entire genome at higher speeds and lower costs. In order to utilize this technology, Abbott scientists had to develop and apply new techniques to help narrow in on the virus portion of the sample to fully sequence and complete the genome.

“Identifying new viruses such as this one is like searching for a needle in a haystack,” said Mary Rodgers, Ph.D., a principal scientist and head of the Global Viral Surveillance Program, Diagnostics, Abbott, and also a co-author of the study. “By advancing our techniques and using next generation sequencing technology, we are pulling the needle out with a magnet. This scientific discovery can help us ensure we are stopping new pandemics in their tracks.”

Advertisement. Scroll to continue reading.

Now this is worth stressing: Existing treatments for HIV that can suppress viral load so that people living with HIV can no longer transmit it, are effective against variants of the HIV virus, including the new subtype. This means – again to emphasize – that a new strain is not a new public health crisis. With the identification of the strain, though, doctors can now test for it.

Abbott created its Global Viral Surveillance Program 25 years ago to monitor HIV and hepatitis viruses and identify mutations to ensure the company’s diagnostic tests remain up to date. In partnership with blood centers, hospitals and academic institutions around the world, Abbott has collected more than 78,000 samples containing HIV and hepatitis viruses from 45 countries, identified and characterized more than 5,000 strains, and published 125 research papers to date to help the scientific community learn more about these viruses. 

Advertisement
Advertisement

Like Us On Facebook

YOU MAY ALSO LIKE

Features

Over 80% of new #HIV infections in the Philippines are under the age of 34, so most of the country's HIV-related efforts focus on...

POZ

Scientists identified the second person to have cured themselves of HIV without medical treatment, according to an article in the Annals of Internal Medicine.

POZ

Different mechanisms suppressed the virus in each person.

POZ

The research involved proteins designed to selectively stimulate the immune system’s CD8+ “killer” T cells to multiply and specifically attack HIV-infected T cells. Co-corresponding...

Advertisement